Geneos Wealth Management Inc. Precision Biosciences Inc Transaction History

Geneos Wealth Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$7.4 - $11.66 $740 - $1,166	-100 Closed	0 $0
Q2 2021 Jul 08, 2021	SELL	$8.07 - $12.52 $1,210 - $1,878	-150 Reduced 60.0%	100 $1,000
Q4 2020 May 19, 2021	BUY	$5.98 - $12.47 $1,495 - $3,117	250 New	250 $2,000
Q2 2020 Sep 07, 2021	SELL	$4.66 - $8.7 $7,223 - $13,484	-1,550 Closed	0 $0
Q4 2019 Sep 07, 2021	BUY	$6.32 - $19.66 $9,796 - $30,473	1,550 New	1,550 $21,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $584M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.